INR 162.3
(1.98%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 96.1 Million INR | -14.97% |
2022 | 113.03 Million INR | -58.93% |
2021 | 275.22 Million INR | 16.61% |
2020 | 236.03 Million INR | 71.35% |
2019 | 137.74 Million INR | 37.02% |
2018 | 100.53 Million INR | -11.88% |
2017 | 114.09 Million INR | 48.19% |
2016 | 76.98 Million INR | 15.1% |
2015 | 66.88 Million INR | -11.22% |
2014 | 75.33 Million INR | 24.97% |
2013 | 60.28 Million INR | 21.0% |
2012 | 49.82 Million INR | -3.44% |
2011 | 51.6 Million INR | -6.21% |
2010 | 55.01 Million INR | 16.42% |
2009 | 47.25 Million INR | 36.15% |
2008 | 34.7 Million INR | -26.12% |
2007 | 46.98 Million INR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2023 FY | 96.1 Million INR | -14.97% |
2023 Q2 | 102.4 Million INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 Q3 | - INR | -100.0% |
2023 Q4 | 96.1 Million INR | 0.0% |
2022 Q4 | 113.03 Million INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2022 Q2 | 218.9 Million INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2022 FY | 113.03 Million INR | -58.93% |
2021 FY | 275.22 Million INR | 16.61% |
2021 Q1 | - INR | -100.0% |
2021 Q2 | 247 Million INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 Q4 | 275.22 Million INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2020 FY | 236.03 Million INR | 71.35% |
2020 Q1 | - INR | -100.0% |
2020 Q2 | 296.1 Million INR | 0.0% |
2020 Q4 | 236.03 Million INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2019 Q2 | 100.8 Million INR | 0.0% |
2019 Q3 | - INR | -100.0% |
2019 Q4 | 137.74 Million INR | 0.0% |
2019 FY | 137.74 Million INR | 37.02% |
2018 Q1 | - INR | -100.0% |
2018 FY | 100.53 Million INR | -11.88% |
2018 Q4 | 100.53 Million INR | 0.0% |
2018 Q3 | - INR | -100.0% |
2018 Q2 | 101.79 Million INR | 0.0% |
2017 Q1 | - INR | -100.0% |
2017 FY | 114.09 Million INR | 48.19% |
2017 Q4 | 114.09 Million INR | 0.0% |
2017 Q3 | - INR | -100.0% |
2017 Q2 | 72.62 Million INR | 0.0% |
2016 Q4 | 76.98 Million INR | 0.0% |
2016 FY | 76.98 Million INR | 15.1% |
2016 Q3 | - INR | -100.0% |
2016 Q2 | 55.96 Million INR | 0.0% |
2016 Q1 | - INR | -100.0% |
2015 Q3 | - INR | -100.0% |
2015 Q4 | 66.88 Million INR | 0.0% |
2015 FY | 66.88 Million INR | -11.22% |
2015 Q1 | - INR | -100.0% |
2015 Q2 | 128.7 Million INR | 0.0% |
2014 Q2 | 92.33 Million INR | 0.0% |
2014 FY | 75.33 Million INR | 24.97% |
2014 Q4 | 75.33 Million INR | 0.0% |
2014 Q3 | - INR | -100.0% |
2014 Q1 | - INR | -100.0% |
2013 Q3 | - INR | -100.0% |
2013 FY | 60.28 Million INR | 21.0% |
2013 Q1 | - INR | -100.0% |
2013 Q2 | 47.7 Million INR | 0.0% |
2013 Q4 | 60.28 Million INR | 0.0% |
2012 Q2 | 72.2 Million INR | 0.0% |
2012 Q4 | 49.82 Million INR | 0.0% |
2012 FY | 49.82 Million INR | -3.44% |
2011 Q4 | 51.6 Million INR | 0.0% |
2011 FY | 51.6 Million INR | -6.21% |
2010 FY | 55.01 Million INR | 16.42% |
2009 FY | 47.25 Million INR | 36.15% |
2008 FY | 34.7 Million INR | -26.12% |
2007 FY | 46.98 Million INR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Ajanta Pharma Limited | 8.28 Billion INR | 98.84% |
Amrutanjan Health Care Limited | 289.04 Million INR | 66.75% |
Sigachi Industries Limited | 707.2 Million INR | 86.41% |
Bal Pharma Limited | 878.11 Million INR | 89.055% |
Ind-Swift Laboratories Limited | 104.57 Million INR | 8.098% |
Medico Remedies Limited | 163.37 Million INR | 41.172% |
Lasa Supergenerics Limited | 190.43 Million INR | 49.532% |
Venus Remedies Limited | 1.21 Billion INR | 92.102% |
Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
Alpa Laboratories Limited | 136.65 Million INR | 29.67% |
Nectar Lifesciences Limited | 7.09 Billion INR | 98.645% |
Shilpa Medicare Limited | 3.44 Billion INR | 97.214% |
Aarti Drugs Limited | 4.85 Billion INR | 98.022% |
Lupin Limited | 49.53 Billion INR | 99.806% |
Aurobindo Pharma Limited | 98.08 Billion INR | 99.902% |
Zydus Lifesciences Limited | 34.41 Billion INR | 99.721% |
Windlas Biotech Limited | 621.89 Million INR | 84.546% |
Suven Life Sciences Limited | 7.08 Million INR | -1256.5% |
Eris Lifesciences Limited | 1.89 Billion INR | 94.916% |
Valiant Laboratories Limited | 100.15 Million INR | 4.04% |
J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 98.087% |
Solara Active Pharma Sciences Limited | 3.59 Billion INR | 97.328% |
Ipca Laboratories Limited | 24.71 Billion INR | 99.611% |
Bliss GVS Pharma Limited | 1.18 Billion INR | 91.886% |
Achyut Healthcare Limited | 568 Thousand INR | -16820.423% |
Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 99.903% |
Bajaj HealthCare Limited | 1.44 Billion INR | 93.328% |
RPG Life Sciences Limited | 1.01 Billion INR | 90.484% |
Mankind Pharma Limited | 15.53 Billion INR | 99.381% |
Laurus Labs Limited | 18.45 Billion INR | 99.479% |
Piramal Pharma Limited | 21.75 Billion INR | 99.558% |
Syncom Formulations (India) Limited | 210.81 Million INR | 54.411% |
Torrent Pharmaceuticals Limited | 22.79 Billion INR | 99.578% |
Alembic Pharmaceuticals Limited | 16.43 Billion INR | 99.415% |
Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 99.618% |
Unichem Laboratories Limited | 7.04 Billion INR | 98.636% |
Sequent Scientific Limited | 3.46 Billion INR | 97.224% |
Novartis India Limited | 448.6 Million INR | 78.576% |
Wanbury Limited | 360.23 Million INR | 73.321% |
Suven Pharmaceuticals Limited | 2.31 Billion INR | 95.843% |
Wockhardt Limited | 6.4 Billion INR | 98.498% |
Themis Medicare Limited | 705.74 Million INR | 86.382% |
Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | 35.915% |
Jubilant Pharmova Limited | 12.89 Billion INR | 99.255% |
Glenmark Life Sciences Limited | 6.66 Billion INR | 98.558% |
Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 99.849% |
Divi's Laboratories Limited | 31.84 Billion INR | 99.698% |
NATCO Pharma Limited | 7 Billion INR | 98.628% |
Gufic Biosciences Limited | 2 Billion INR | 95.206% |
IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 97.738% |
Ind-Swift Limited | 640.91 Million INR | 85.005% |
Procter & Gamble Health Limited | 1.09 Billion INR | 91.192% |
FDC Limited | 3.88 Billion INR | 97.529% |
Krebs Biochemicals & Industries Limited | 97.96 Million INR | 1.895% |
Granules India Limited | 13 Billion INR | 99.261% |
Medicamen Biotech Limited | 593.75 Million INR | 83.813% |
Alkem Laboratories Limited | 26.61 Billion INR | 99.639% |
AstraZeneca Pharma India Limited | 2.27 Billion INR | 95.783% |
Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -276.938% |
Megasoft Limited | - INR | -Infinity% |
ZIM Laboratories Limited | 812.62 Million INR | 88.173% |
Strides Pharma Science Limited | 11.26 Billion INR | 99.147% |
Neuland Laboratories Limited | 3.5 Billion INR | 97.257% |
Morepen Laboratories Limited | 2.48 Billion INR | 96.134% |
Hikal Limited | 3.03 Billion INR | 96.836% |
Indoco Remedies Limited | 3.53 Billion INR | 97.278% |
Aarti Pharmalabs Limited | 6.42 Billion INR | 98.505% |
Kilitch Drugs (India) Limited | 39.88 Million INR | -140.993% |
Mangalam Drugs & Organics Limited | 1.23 Billion INR | 92.227% |
Hester Biosciences Limited | 755.81 Million INR | 87.284% |